Brought to you by:
UK-COMPASS: Aortas, open surgical skills and gratitude
As you read this, you are probably wondering why the heck I am writing an editorial on complex aortic aneurysms when you know I am somewhere in the South focused on vascular trauma and limb ischemia. Well, no good deed…
UK-COMPASS: Aortas, open surgical skills and gratitude
As you read this, you are probably wondering why the heck I am writing an editorial on complex aortic aneurysms when you know I am somewhere in the South focused on vascular trauma and limb ischemia. Well, no good deed…
The ability of ChatGPT to further patient education and aid surgeons
ChatGPT 4.0 was able to provide a mean accuracy rating of 4.4 on a Likert scale of 5 (1=very poor; 5=excellent) across 15 patient-level questions designed to assess the ability of the artificial intelligence (AI)-driven large language model to provide…
Nectero Medical receives FDA clearance of IND application to initiate Phase II/III clinical trial of Nectero EAST system
Nectero Medical today announced that the US Food and Drug Administration (FDA) has granted investigational new drug (IND) clearance for the company to initiate a prospective, multicentre, randomised clinical trial (the stAAAble study) to evaluate the safety and efficacy of…
Bias and the silver bullet: Gender partiality seen within AI algorithms for AAA identification
Artificial intelligence (AI) has become a central focus within various spheres, from commerce to medicine—including applications in patient care. Sharon Kiang, MD, talks to Vascular Specialist about the specter of bias and how a “hybrid” approach between AI and human…
Five-year results of the LEOPARD trial published in the Journal of Vascular Surgery
Endologix has announced the online publication of the final five-year results of the LEOPARD trial in the Journal of Vascular Surgery (JVS). The study’s findings showed that there was no significant difference in aneurysm-related outcomes between patients randomized to the…
CX 2023: Statins save lives after aortic repair regardless of dose
Statin treatment after aortic repair is associated with improved long-term survival, while dose does not matter. This was the key message from a first-to-podium presentation delivered by Kevin Mani (Uppsala University, Uppsala, Sweden) at the 2023 Charing Cross (CX) International…
The top 10 most popular Vascular Specialist stories of April 2023
In April 2023, Vascular Specialist readers were drawn to an interview dissecting the role robotics play, and can play in the future, in vascular surgery; a report of a new study that trialled the explantation of mature arteriovenous fistulas (AVFs)…
Award-winning paper finds F/BEVAR ‘feasible and safe’ in patients with failed aortic repairs
Presenting award-winning new research, Andrea Vacirca, MD, a research fellow at The University of Texas Health Science Center in Houston (UTHealth Houston), revealed how, despite prior records which demonstrate that fenestrated-branched endovascular aortic repair (F/BEVAR) is “feasible and safe” in…
The top 10 most popular Vascular Specialist stories of March 2023
In March 2023, the Vascular Specialist stories grabbing readers’ attention were a response to a February letter addressing vascular surgeons’ use of social media; an interview with an advocate for more carefully considered use of venous stents; the publication of the…